Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat - PubMed (original) (raw)

doi: 10.1038/ncomms12152.

Kayoko Hosaka 1, Sharon Lim 1, Carina Fischer 1, Jennifer Honek 1, Yunlong Yang 1, Patrik Andersson 1, Masaki Nakamura 1, Erik Näslund 2, Seppo Ylä-Herttuala 3, Meili Sun 1, Hideki Iwamoto 1, Xuri Li 4, Yizhi Liu 4, Nilesh J Samani 5, Yihai Cao 1 5

Affiliations

Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat

Takahiro Seki et al. Nat Commun. 2016.

Abstract

Cold- and β3-adrenoceptor agonist-induced sympathetic activation leads to angiogenesis and UCP1-dependent thermogenesis in mouse brown and white adipose tissues. Here we show that endothelial production of PDGF-CC during white adipose tissue (WAT) angiogenesis regulates WAT browning. We find that genetic deletion of endothelial VEGFR2, knockout of the Pdgf-c gene or pharmacological blockade of PDGFR-α impair the WAT-beige transition. We further show that PDGF-CC stimulation upregulates UCP1 expression and acquisition of a beige phenotype in differentiated mouse WAT-PDGFR-α(+) progenitor cells, as well as in human WAT-PDGFR-α(+) adipocytes, supporting the physiological relevance of our findings. Our data reveal a paracrine mechanism by which angiogenic endothelial cells modulate adipocyte metabolism, which may provide new targets for the treatment of obesity and related metabolic diseases.

PubMed Disclaimer

Figures

Figure 1

Figure 1. β3-adrenoceptor-dependent activation of adipose angiogenesis and the beige phenotype in visceral adipose tissue.

(a) Microvessels (CD31+ red), adipocyte morphology (H&E; Perilipin+ green), and mitochondrial staining (Prohibitin+ red) of buffer-treated control (vehicle) and CL-treated gWAT in wild-type (wt) and Adrb3 −/− mice. White arrows and arrowheads point to microvessels and double-arrowed bars indicate adipocyte diameter. Yellow arrows point to prohibitin-positive signals. Cold (4 °C)- and thermoneutral temperature (30 °C)-exposed gWAT served as controls. _n_=5 mice for each group. (b) Quantification of microvessel density in various agent- or temperature-treated groups (_n_=10 random fields; _n_=5 mice for each group). (c) Quantification of average adipocyte size (>30 adipocytes per field; _n_=10 random fields; _n_=5 mice for each group). (d) Quantification of prohibitin-positive signals in various agents- or temperature-treated groups (_n_=10 random fields; _n_=5 mice for each group). (e) Vegf mRNA and protein expression in vehicle- and CL-treated gWAT samples. Total adipose tissue, MAF and SVF were used as starting materials (_n_=5 samples for each group). (f) UCP1 staining of gWAT in various agents- or temperature-treated wt and Adrb3 −/− mice. (_n_=5 samples for each group). Arrowheads point to UCP1-positive signals. Red=UCP1; green=perilipin; blue=DAPI. (g) Quantification of UCP1-positive staining signals (left, _n_=10 random fields) and mRNA (right, _n_=6–8 samples for each group). All scale bars, 50 μm. **P<0.01; ***P<0.001 by two-sided unpaired _t_-test. Data presented as mean±s.e.m. DAPI, 4',6-diamidino-2-phenylindole. n.s., not significant.

Figure 2

Figure 2. CL induces UCP1-independent adipose angiogenesis and upregulates VEGFR expression levels.

(a) Microvessels (CD31+ red), adipocyte morphology (H&E; perilipin+ green), and UCP1 expression (UCP1+ red) of vehicle- and CL-gWAT in wt and Ucp1 −/− mice. White arrows and arrowheads in upper three panels point to microvessels. Arrows in the lowest row of panels indicate UCP1-positive signals. Double-arrowed bars mark adipocyte diameter. _n_=5 mice for each wt and Ucp1 −/− group. (b) Quantification of microvessel density in vehicle- and CL-treated wt and Ucp1 −/− mice (_n_=10 random fields; _n_=5 mice for each group). (c) Quantification of the average adipocyte size (>30 adipocytes/field; _n_=10 random fields; _n_=5 mice for each group). (d) Vegf mRNA expression levels in vehicle- and CL-treated total gWAT (left) and MAF (right) samples in wt and Ucp1 −/− mice (_n_=10 samples for each group). (e) Quantification of UCP1-positive signals (_n_=10 random fields; _n_=5 mice for each group). (f) Vegfr1 and Vegfr2 mRNA expression levels in vehicle- and CL-treated total gWAT samples in wt mice (_n_=10 samples for each group). (g) FACS analysis of VEGFR1 and VEGFR2 expression levels in CD31+ and CD31− ECs isolated from vehicle- and CL-treated gWAT in wt mice (_n_=5 samples for each group). All scale bars, 50 μm. **P<0.01; ***P<0.001 by two-sided unpaired _t_-test. Data presented as mean±s.e.m. n.s., not significant.

Figure 3

Figure 3. Effects of VEGF and VEGFR blockades on CL-induced adipose angiogenesis and beige phenotype.

(a) Microvessels (CD31+ red), adipocyte morphology (H&E; perilipin+ green) and UCP1 expression (UCP1+ red) of CL-treated gWAT in mice that were treated with vehicle, VEGF-, and VEGFR2-specific neutralizing antibodies (Anti-VEGF and Anti-R2) and sunitinib. The vehicle- treated group served as a control. White arrows and arrowheads in upper three panels point to microvessels. Arrows in the lowest row of panels indicate UCP1-positive signals. Double-arrowed bars mark adipocyte diameter. Green=perilipin; blue=DAPI. _n_=8 for each vehicle, VEGF and VEGFR blockades group. (b) Quantification of microvessel density in vehicle- and CL-treated wt mice that received treatment with various VEGF blockades (_n_=10 random fields; _n_=8 mice for each group). (c) Quantification of average adipocyte size (>30 adipocytes/field; _n_=10 random fields; _n_=8 mice for each group). (d) Quantification of UCP1-positive signals (_n_=10 random fields; _n_=8 mice for each group). (e) Norepinephrine-stimulated non-shivering thermogenesis in VEGF/VEGFR blockade- and vehicle-treated mice that received CL or buffer (_n_=5 mice for each group). All scale bars, 50 μm. *P<0.05; **P<0.01; ***P<0.001 by two-sided unpaired _t_-test. Data presented as mean±s.e.m. NE, norepinephrine.

Figure 4

Figure 4. Impaired CL-induced angiogenesis and beige transition in EC _Vegfr2_-specific eliminated mice.

(a) Microvessels (CD31+ red), adipocyte morphology (H&E; perilipin+ green), and UCP1 expression (UCP1+ red) of vehicle- and CL-treated gWAT in wt and Flk1f/f;Cdh5CreER T2 mice. White arrows and arrowheads in upper three panels point to microvessels. Arrows in the lowest row of panels indicate UCP1-positive signals. Double-arrowed bars mark adipocyte diameter. _n_=5 for each wt and Flk1f/f;Cdh5CreER T2 group. (b) Quantification of microvessel density in vehicle- and CL-treated wt and Flk1f/f;Cdh5CreER T2 mice (_n_=10 random fields; _n_=5 mice for each group). (c) Quantification of average adipocyte size (>30 adipocytes/field; _n_=10 random fields; _n_=5 mice for each group). (d) Quantification of UCP1-positive signals (_n_=10 random fields; _n_=5 mice for each group). (e) qPCR quantification of mRNA expression levels Ucp1, Cidea, Cox8b, Pgc1α and Prdm16 in vehicle- and CL-treated total gWAT samples in wt and Flk1f/f;Cdh5CreER T2 mice. (_n_=10 samples for each group). All scale bars, 50 μm. **P<0.01; ***P<0.001 by two-sided unpaired _t_-test. Data presented as mean±s.e.m.

Figure 5

Figure 5. Microarray and effect of AdVEGF delivery on adipose angiogenesis and CL-induced PDGF-C expression during beige transition.

(a) Histological images of microvessels (CD31+ red, white arrows and arrow heads), adipocyte morphology (H&E, double-arrowed bars, perilipin+green), and UCP1 (UCP1+ red, white arrows) in mice that were treated with AdGFP and AdVEGF for 10 days. The non-adenovirus-treated (NAT) group served as a control. _n_=5 mice for NAT group, _n_=10 mice for each AdGFP and AdVEGF group. (b) Quantification of Vegf mRNA expression levels in NAT- AdGFP- and AdVEGF-treated total gWAT. Quantification of microvessel density in NAT- AdGFP- and AdVEGF-treated (_n_=10 random fields; _n_=5 mice for NAT and _n_=10 for each AdGFP and AdVEGF group). (c) Quantification of UCP1-positive signals (_n_=10 random field; _n_=5 mice for NAT group and _n_=10 for each AdGFP and AdVEGF group) and quantification of Ucp1 mRNA expression levels by qPCR (_n_=10 samples for each group). (d) Quantification of average adipocyte size (>30 adipocytes/field; _n_=10 random fields; _n_=5 mice for NAT group and _n_=10 for each AdGFP and AdVEGF group). (e) Norepinephrine-stimulated non-shivering thermogenesis in AdGFP or AdVEGF-treated gWAT of mice (_n_=5 mice for each group). NE, norepinephrine. (f) Hierarchical clusters of top 20 growth factors and cytokines from genome-wide microarray analysis (_n_=3 samples for each group). qPCR analysis of Pdgf-c mRNA expression levels of vehicle- and CL-treated gWAT SVF (_n_=5 samples for each group). (g) Quantification of Pdgf-c mRNA expression levels in SVF by qPCR in AdGFP- and AdVEGF-treated total gWAT (_n_=10 samples). (h) QPCR analysis of Pdgf-a, -b, -c, and -d expression levels in total vehicle- and CL-treated CD31+ EC fraction from gWAT. (i) Pdgf-c mRNA expression levels in vehicle- and CL-treated total gWAT of wt and Flk1f/f;Tie2CreER T2 mice. All scale bars, 50 μm. *P<0.05; **P<0.01 by two-sided unpaired _t_-test. Data presented as mean±s.e.m. n.s., not significant.

Figure 6

Figure 6. Impaired CL-induced beige transition in Pdgf-c −/− mice and gain-of-function by delivery of AdPDGFC.

(a) Histological images of microvessels (CD31+ red, white arrows and arrow heads), adipocyte morphology (H&E, double arrowed bars, perilipin+green), and UCP1 (UCP1+ red, white arrows). _n_=5 mice for each wt and Pdgf-c _−/−_group. (b) Quantification of microvessel density in vehicle- and CL-treated gWAT in wt and Pdgf-c −/− mice. (_n_=10 random fields; _n_=5 mice for each group). (c) Quantification of average adipocyte size (>30 adipocytes/field; _n_=10 random fields; _n_=5 mice for each group). (d) Quantification of UCP1-positive signals (_n_=10 random fields; _n_=5 mice for each group). (e) qPCR quantification of browning markers' expression levels in vehicle- and CL-treated total gWAT samples in wt and Pdgf-c −/− mice. (_n_=10 samples for each group). (f) Delivery of AdPDGFC to gWAT of CL-injected Pdgf-c −/− mice. Arrows point to CD31+ microvessels and arrowheads point to UCP1-positive signals. Quantification of CD31+ and UCP1+ signals (_n_=10 randomized fields). _n_=8 mice for each wt and Pdgf-c −/− group. (g) qPCR quantification of browning markers' expression levels in AdGFP- and AdPDGFC-injected gWAT of CL-treated Pdgf-c _−/−_mice (_n_=12 samples for each group). (h) Delivery of AdPDGFC or AdGFP to gWAT of NOD-SCID mice. Arrows point to CD31+ microvessels and arrowheads point to UCP1-positive signals. (i) Quantification of CD31+ and UCP1+ signals (_n_=10 randomized fields; _n_=8 mice for each group). (j) Pdgf-c expression level in iWAT by delivery of AdPDGFC, body weight curve and adipose depot weights of HFD-induced obese mice receiving AdGFP and AdPDGFC treatment (_n_=6 animals for each group). (k) Insulin tolerance of AdGFP- and AdPDGFC-treated HFD-induced obese mice (_n_=10 animals for each group). The Mann–Whitney test. All scale bars, 50 μm. *P<0.05; **P<0.01; ***P<0.001 by two-sided unpaired _t_-test. Data presented as mean±s.e.m. n.s., not significant.

Figure 7

Figure 7. PDGF-CC promotes adipose progenitor cell differentiation toward a beige phenotype and PDGFR-α blockade CL-induced beige transition.

(a) Localization of PDGFR-α+ cells, the quantification, FACS analysis, and Pdgfra mRNA expression in vehicle- and CL-treated gWAT of wt mice (_n_=4 for staining and _n_=6 for FACS; _n_=10 for quantification; _n_=6 for qPCR). (b) qPCR analysis of browning markers' expression levels by PDGF-CC stimulation in differentiated gWAT-PDGFR-α+ cell populations. (c) Oil Red O staining and qPCR analysis (_n_=9 samples for each group) in human differentiated PDGFR-α− and PDGFR-α+ cells. (d) Histological images of microvessels (CD31+ red, white arrows and arrow heads), adipocyte morphology (H&E, double arrowed bars; perilipin+green), and UCP1 (UCP1+ red, white arrows). (e) Quantification of microvessel density in vehicle- and CL-treated gWAT in wt mice that received PRα and PRβ blockade treatment (_n_=10 random fields; _n_=8 mice for each group). (f) Quantification of average gWAT adipocyte size (>30 adipocytes/field; _n_=10 random fields; _n_=8 mice for each group). (g) Quantification of UCP1-positive signals (_n_=10 random fields; _n_=8 mice for each group). (h) qPCR quantification of browning markers' expression levels in gWAT from wt mice that received various treatments. (i) Norepinephrine-stimulated non-shivering thermogenesis in PRα and PRβ blockade- and vehicle-treated mice that received CL or buffer (_n_=5 mice for each group). NE, norepinephrine. (j) Norepinephrine-stimulated non-shivering thermogenesis in PRα and PRβ blockade- and vehicle-treated mice that had been exposed to 4 or 30 °C (_n_=5 mice for each group). (k) Schematic diagram of paracrine regulatory mechanisms by which the VEGF-VEGFR2 and PDGF-CC-PDGFR-α signalling systems cohesively and reciprocally control adipose endothelial cell-adipocyte crosstalk, leading to the transition of beige cell differentiation from PDGFR-α+ cells in WAT. AR, adrenoceptor; BA, brown adipocyte; WA, white adipocyte. All scale bars, 50 μm. *P<0.05; **P<0.01; ***P<0.001 by two-sided unpaired _t_-test. Data presented as mean±s.e.m. n.s., not significant.

Comment in

References

    1. Cao Y. Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 117, 2362–2368 (2007). - PMC - PubMed
    1. Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug Discov. 9, 107–115 (2010). - PubMed
    1. Gupta R. K. et al.. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab. 15, 230–239 (2012). - PMC - PubMed
    1. Tran K. V. et al.. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab. 15, 222–229 (2012). - PMC - PubMed
    1. Brissova M. et al.. Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function. Diabetes 55, 2974–2985 (2006). - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources